GlassScriptPhysician profile
Mark J Stamm
NPI 1922082387
$2,044.29
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $357 · 2021: $316 · 2022: $467 · 2023: $238 · 2024: $76.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $418.64 | 2019-2021 | |
| Novo Nordisk INC | $250.00 | 2019 | |
| Abbvie INC. | $246.23 | 2022-2023 | Durysta |
| Sun Pharmaceutical Industries INC. | $230.67 | 2019-2023 | Cequa |
| Alcon Vision LLC | $224.06 | 2019-2023 | Argos |
| Novartis Pharmaceuticals Corporation | $171.67 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $113.78 | 2021 | |
| Eyepoint US, INC. | $80.02 | 2020-2021 | |
| Harrow Eye, LLC | $50.92 | 2024 | Vevye |
| Notal Vision, INC. | $46.64 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $25.41 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $24.65 | 2020 | |
| Omeros Corporation | $21.31 | 2019 | |
| Bausch & Lomb Americas INC. | $20.84 | 2023 | Xiidra |
| Mallinckrodt Enterprises LLC | $18.96 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.61 | 2019 | |
| Spark Therapeutics, INC. | $17.73 | 2019 | |
| Shire North American Group INC | $17.33 | 2019 | |
| Biotissue Holdings INC. | $16.79 | 2021 | |
| Oyster Point Pharma, INC. | $16.67 | 2022 | |
| Kala Pharmaceuticals, INC. | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Stamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.